Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Little Zebra Fund is a physician-led 501(c)(3) non-profit organization dedicated to expanding access to clinical genetic testing for patients with undiagnosed or ultra-rare diseases. Founded in 2018 by medical geneticists Dr. Maura Ruzhnikov and Dr. Gretchen Foskett, the fund provides financial assistance to families whose insurance has denied coverage for necessary diagnostic tests, such as exome or whole genome sequencing. By eliminating financial barriers, the organization aims to end the "diagnostic odyssey" for patients and facilitate timely medical interventions. The fund has recently transitioned its operations to become a permanent campaign under the umbrella of the Undiagnosed Diseases Network Foundation (UDNF).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Little Zebra Fund.